https://www.selleckchem.com/pr....oducts/chloroquine.h
Interestingly, PhiDP23.1 was only found in UC patients before and after QYSX treatment. In addition, Bifidobacterium, Bacteroidetes, Prevotellaceae, Actinobacteria, and Corynebacteriales were the biomarkers in UC patients after QYSX treatment due to their high abundance. GO terms and KEGG analysis showed that the identified gut microbiome was involved in many biological processes and pathways. Conclusions QYSX could regulate disordered gut microbiome and phages, indicating that QYSX has great therapeutic potential for UC.Objective T
Mi piace
Commento
Condividi
